Quick HIV meds may slash stigma for drug users

NCT ID NCT06541028

Recruiting now Disease control Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether starting antiretroviral therapy within 7 days of an HIV diagnosis can reduce stigma and improve health outcomes for people who inject drugs. Researchers will develop a rapid-start strategy and pilot it with 135 participants at HIV clinics. The goal is to lower stigma and viral load, making it easier for this group to stay healthy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: rapid-start antiretroviral therapy (ART) within 7 days of diagnosis
What this could lead to: If successful, this could show that starting HIV treatment quickly after diagnosis reduces stigma and improves viral suppression in people who inject drugs.
What could go wrong: This is a small pilot study (135 participants) testing a behavioral strategy, not a new drug. Results may not apply to all clinics or populations, and stigma is complex to change.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG USE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease substance abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRUG USE HIV

Contacts and locations

Locations

Centre of Excellence for Research in AIDS (CERiA) - University of Malaya
ACTIVE_NOT_RECRUITING

Kuala Lumpur, 50450, Malaysia
Kajang Prison
RECRUITING

Kajang, 43000, Malaysia
Primary Healthcare Centers
RECRUITING

Kuala Lumpur, 50450, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.